Halozyme Therapeutics, Inc. (HALO) SEC Filings — 2025
19 SEC filings for Halozyme Therapeutics, Inc. (HALO) in 2025.
Filings
- Halozyme Therapeutics Announces Executive and Board Changes — 8-K · Dec 9, 2025
- Halozyme Therapeutics Reports Executive Compensation Changes — 8-K · Dec 8, 2025
- Halozyme Therapeutics, Inc. 8-K Filing — 8-K · Nov 24, 2025
- Halozyme Therapeutics Files 8-K with Key Agreements and Securities Info — 8-K · Nov 12, 2025
- Halozyme Therapeutics Files 8-K — 8-K · Nov 7, 2025
- Halozyme Therapeutics, Inc. 8-K Filing — 8-K · Nov 5, 2025
- Halozyme's Royalties Fuel 49% Net Income Surge in Q3 — 10-Q · Nov 3, 2025
- Halozyme Therapeutics Files 8-K — 8-K · Oct 14, 2025
- Halozyme Therapeutics Announces Executive & Director Changes — 8-K · Oct 6, 2025
- Halozyme Therapeutics Files 8-K for Material Agreement — 8-K · Oct 3, 2025
- Halozyme Therapeutics Files 8-K — 8-K · Oct 1, 2025
- Halozyme Therapeutics, Inc. 10-Q Filing — 10-Q · Aug 5, 2025
- Halozyme Therapeutics Files Q1 2025 10-Q — 10-Q · May 6, 2025
- Halozyme Therapeutics Files 8-K on Security Holder Vote — 8-K · May 2, 2025
- Halozyme Therapeutics Reports Director and Officer Changes — 8-K · Mar 21, 2025
- Halozyme Therapeutics Executive Compensation Revealed — DEF 14A · Mar 18, 2025
- Halozyme Therapeutics Files 2024 10-K — 10-K · Feb 18, 2025
- Halozyme Therapeutics Announces Executive and Board Changes — 8-K · Feb 13, 2025
- Halozyme Therapeutics Files 8-K on Financials — 8-K · Jan 8, 2025